Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus

Emory University

Status and phase: Terminated; Phase 2

Conditions: Esophageal Diseases

Treatments: Drug: Taxol, Cisplatin, 5-Fluorouracil, G-CSF

Study type: Interventional

Funder types: Other

Identifiers

NCT00208936

0691-1995

Details and patient eligibility

About

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

Full description

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.

Exclusion criteria

• Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)